\
&
Contact us
\
&
Contact us
Published on | 1 month ago
ProgrammesThe C4B Open Call funds pilot projects aimed at testing, validating, adapting or replicating circular bio-based business models in concrete regional and business contexts.
The target groups include, among others, farmers, foresters, groups of primary producers, SMEs, start-ups, agricultural and forestry industry actors, bio-based industry stakeholders, sectoral organisations and multi-actor partnerships.
The main topics covered include circular bioeconomy, sustainability, fairness in value chains, and the replicability and scalability of bio-based business models.
Selected projects may receive up to €60,000 per project, for an implementation period of up to 12 months. The deadline for application is 14 August 2026. Further info can be found here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Agro-Food, Environment
The 2nd EO 4 Soil Symposium is organised by the European Space Agency (ESA) and focusses on three thematic areas: policy and user uptake scientific and technical progress applications and use cases Topics include soil monitoring methods, soil organic carbon mapping, uncertainty assessment, data harmonisation, soil carbon certific... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
